Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Endo Recalls Erectile Dysfunction Injection

Endo Pharmaceuticals Inc. voluntarily recalls one lot of Edex due to potential lack of sterility assurance.

Endo's Edex Injection / Image: edguidance.com
Endo's Edex Injection / Image: edguidance.com

On Monday, February 27th the FDA announced the Endo Pharmaceutical’s voluntary nationwide recall of Edex, a prescription only intracavernous injection used in the treatment of male erectile dysfunction. Lot 207386 is believed to contain a defect in the crimp caps used in the manufacture, which could lead to a loss of container closure integrity and sterility.

The recall only applies to the 10 mcg strength version, which is packaged in a two-pack carton. The affected lot was distributed throughout the U.S. between Decmeber and February. Consumers in possession of products from the affected lot should discontinue use and return any unused product.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging